Pragmatic Use of Next-generation Sequencing to Improve Management of Drug-resistant Tuberculosis
Conditions: Drug-resistant Tuberculosis; HIV Coinfection; Cost-Benefit Analysis Intervention: Diagnostic Test: Targeted next-generation sequencing Sponsors: University of California, San Francisco; University of Stellenbosch; National Health Laboratory Service (NHLS), South Africa; National Institute for Communicable Diseases, South Africa; Translational Genomics Research Institute; National Institute of Allergy and Infectiou s Diseases (NIAID); University Hospital Heidelberg Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Allergy | Allergy & Immunology | Laboratory Medicine | Research | South Africa Health | Tuberculosis